Probing the substrate specificity of the ergothioneine transporter with methimazole, hercynine, and organic cations

Biochemical Pharmacology

Volumn 74, Issue 2, 2007, Pages 309-316

  Grigat, Silke ^a   Harlfinger, Stephanie ^a   Pal, Sonia ^a   Striebinger, Ralph ^a   Golz, Stefan ^b   Geerts, Andreas ^b   Lazar, Andreas ^a   Schömig, Edgar ^a   Gründemann, Dirk ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b BAYER PHARMA AG   (Germany)

Author keywords

Chronic inflammatory disease; Ergothioneine; Ergothioneine transporter; Methimazole; Organic cations; SLC22A4

Indexed keywords

ANTITHYROID AGENT; ERGOTHIONEINE TRANSPORTER; HERCYNINE; MEPYRAMINE; ORGANIC CATION TRANSPORTER 1; QUINIDINE; THIAMAZOLE; THIONEINE; UNCLASSIFIED DRUG; VERAPAMIL;

ARTICLE; BONE MARROW; CHRONIC INFLAMMATION; CONTROLLED STUDY; DNA POLYMORPHISM; DRUG STRUCTURE; ENZYME SPECIFICITY; ETT GENE; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

BETAINE; BIOLOGICAL TRANSPORT; CELLS, CULTURED; ERGOTHIONEINE; HISTIDINE; HUMANS; METHIMAZOLE; ORGANIC CATION TRANSPORT PROTEINS; RNA, MESSENGER; SUBSTRATE SPECIFICITY;

EID: 34249985502     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2007.04.015     Document Type: Article

References (40)

1. Melville D.B. Ergothioneine. Vitam Horm 17 (1958) 155-204
2. Hartman PE. Ergothioneine as antioxidant. Methods in enzymology, vol. 186. Academic Press; 1990. p. 310-18.
3. Gründemann D., Harlfinger S., Golz S., Geerts A., Lazar A., Berkels R., et al. Discovery of the ergothioneine transporter. Proc Natl Acad Sci USA 102 (2005) 5256-5261
4. Peltekova V.D., Wintle R.F., Rubin L.A., Amos C.I., Huang Q., Gu X., et al. Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nat Genet 36 (2004) 471-475
5. Martinez A., Del Carmen Martin M., Mendoza J.L., Taxonera C., Diaz-Rubio M., de la Concha E.G., et al. Association of the organic cation transporter OCTN genes with Crohn's disease in the Spanish population. Eur J Hum Genet 14 (2006) 222-226
6. Leung E., Hong J., Fraser A.G., Merriman T.R., Vishnu P., and Krissansen G.W. Polymorphisms in the organic cation transporter genes SLC22A4 and SLC22A5 and Crohn's disease in a New Zealand Caucasian cohort. Immunol Cell Biol 84 (2006) 233-236
7. Babusukumar U., Wang T., McGuire E., Broeckel U., and Kugathasan S. Contribution of OCTN variants within the IBD5 locus to pediatric onset Crohn's disease. Am J Gastroenterol 101 (2006) 1354-1361
8. Fisher S.A., Hampe J., Onnie C.M., Daly M.J., Curley C., Purcell S., et al. Direct or indirect association in a complex disease: the role of SLC22A4 and SLC22A5 functional variants in Crohn disease. Hum Mutat 27 (2006) 778-785
9. Waller S., Tremelling M., Bredin F., Godfrey L., Howson J., and Parkes M. Evidence for association of OCTN genes and IBD5 with ulcerative colitis. Gut 55 (2006) 809-814
10. Santiago J.L., Martinez A., de la Calle H., Fernandez-Arquero M., Figueredo M.A., de la Concha E.G., et al. Evidence for the association of the SLC22A4 and SLC22A5 genes with type 1 diabetes: a case control study. BMC Med Genet 7 (2006) 54 (Electronic resource)
11. Tokuhiro S., Yamada R., Chang X., Suzuki A., Kochi Y., Sawada T., et al. An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis. Nat Genet 35 (2003) 341-348
12. Barton A., Eyre S., Bowes J., Ho P., John S., and Worthington J. Investigation of the SLC22A4 gene (associated with rheumatoid arthritis in a Japanese population) in a United Kingdom population of rheumatoid arthritis patients. Arthritis Rheum 52 (2005) 752-758
13. Martinez A., Valdivia A., Pascual-Salcedo D., Balsa A., Fernandez-Gutierrez B., De la Concha E., et al. Role of SLC22A4, SLC22A5, and RUNX1 genes in rheumatoid arthritis. J Rheumatol 33 (2006) 842-846
14. Tamai I., Yabuuchi H., Nezu J.-I., Sai Y., Oku A., Shimane M., et al. Cloning and characterization of a novel human pH-dependent organic cation transporter OCTN1. FEBS Lett 419 (1997) 107-111
15. Yabuuchi H., Tamai I., Nezu J.-I., Sakamoto K., Oku A., Shimane M., et al. Novel membrane transporter OCTN1 mediates multispecific, bidirectional, and pH-dependent transport of organic cations. J Pharmacol Exp Ther 289 (1999) 768-773
16. Balazs C., Kiss E., Leovey A., and Farid N.R. The immunosuppressive effect of methimazole on cell-mediated immunity is mediated by its capacity to inhibit peroxidase and to scavenge free oxygen radicals. Clin Endocrinol 25 (1986) 7-16
17. Weetman A.P., Holt M.E., Campbell A.K., Hall R., and McGregor A.M. Methimazole and generation of oxygen radicals by monocytes: potential role in immunosuppression. Br Med J (Clin Res Ed) 288 (1984) 518-520
18. Lechpammer M., Lukac J., Lechpammer S., and Kusic Z. Antithyroid drug-induced immunomodulation in Graves' disease patients. Acta Med Croatica 56 (2002) 21-26
19. Lagorce J.F., Moulard T., Rousseau A., Comby F., Buxeraud J., and Raby C. Anti-inflammatory action of methimazole. Pharmacology 55 (1997) 173-178
20. Bach M., Grigat S., Pawlik B., Fork C., Utermöhlen O., Pal S., et al. Fast set-up of doxycycline-inducible protein expression in human cell lines with a single plasmid based on Epstein-Barr virus replication and the simple tetracycline repressor. FEBS J 274 (2007) 783-790
21. Reinhold V.N., Ishikawa Y., and Melville D.B. Synthesis of alpha-N-methylated histidines. J Med Chem 11 (1968) 258-260
22. Gründemann D., Liebich G., Kiefer N., Köster S., and Schömig E. Selective substrates for non-neuronal monoamine transporters. Mol Pharmacol 56 (1999) 1-10
23. Schömig E., Babin-Ebell J., and Russ H. 11′-Diethyl-2,2′-cyanine (decynium22) potently inhibits the renal transport of organic cations. Naunyn-Schmiedebergs Arch Pharmacol 347 (1993) 379-383
24. Harlfinger S., Fork C., Lazar A., Schömig E., and Gründemann D. Are organic cation transporters capable of transporting prostaglandins?. Naunyn-Schmiedebergs Arch Pharmacol 372 (2005) 125-130
25. Watanabe C., Kato Y., Sugiura T., Kubo Y., Wakayama T., Iseki S., et al. PDZ Adaptor protein PDZK2 stimulates transport activity of organic cation/carnitine transporter OCTN2 by modulating cell surface expression. Drug Metab Dispos 34 (2006) 1927-1934
26. Inazu M., Takeda H., Maehara K., Miyashita K., Tomoda A., and Matsumiya T. Functional expression of the organic cation/carnitine transporter 2 in rat astrocytes. J Neurochem 97 (2006) 424-434
27. Wu X., George R.L., Huang W., Wang H., Conway S.J., Leibach F.H., et al. Structural and functional characteristics and tissue distribution pattern of rat OCTN1, an organic cation transporter, cloned from placenta. Biochim Biophys Acta 1466 (2000) 315-327
28. Schömig E., Lazar A., and Gründemann D. Extraneuronal monoamine transporter and organic cation transporters 1 and 2-a review of transport efficiency. In: Sitte H.H., and Freissmuth M. (Eds). Handbook of experimental pharmacology-neurotransmitter transporters (2006), Springer, Heidelberg 151-180
29. Eskandari S., Wright E.M., Kreman M., Starace D.M., and Zampighi G.A. Structural analysis of cloned plasma membrane proteins by freeze- fracture electron microscopy. Proc Natl Acad Sci USA 95 (1998) 11235-11240
30. Gründemann D., Schechinger B., Rappold G.A., and Schömig E. Molecular identification of the corticosterone-sensitive extraneuronal monoamine transporter. Nature Neurosci 1 (1998) 349-351
31. Gründemann D., Babin-Ebell J., Martel F., Örding N., Schmidt A., and Schömig E. Primary structure and functional expression of the apical organic cation transporter from kidney epithelial LLC-PK1 cells. J Biol Chem 272 (1997) 10408-10413
32. Weetman A.P., Gunn C., Hall R., and McGregor A.M. The accumulation of [35S]methimazole by monocytes and macrophages. Acta Endocrinol 107 (1984) 366-370
33. Smith R.C., Reeves J.C., Dage R.C., and Schnettler R.A. Antioxidant properties of 2-imidazolones and 2-imidazolthiones. Biochem Pharmacol 36 (1987) 1457-1460
34. Akanmu D., Cecchini R., Aruoma O.I., and Halliwell B. The antioxidant action of ergothioneine. Arch Biochem Biophys 288 (1991) 10-16
35. Franzoni F., Colognato R., Galetta F., Laurenza I., Barsotti M., Di Stefano R., et al. An in vitro study on the free radical scavenging capacity of ergothioneine: comparison with reduced glutathione, uric acid and trolox. Biomed Pharmacother 60 (2006) 453-457
36. Kobayashi D., Aizawa S., Maeda T., Tsuboi I., Yabuuchi H., Nezu J., et al. Expression of organic cation transporter OCTN1 in hematopoietic cells during erythroid differentiation. Exp Hematol 32 (2004) 1156-1162
37. Alayash A.I. Oxygen therapeutics: can we tame haemoglobin?. Nat Rev 3 (2004) 152-159
38. Arduini A., Mancinelli G., Radatti G.L., Hochstein P., and Cadenas E. Possible mechanism of inhibition of nitrite-induced oxidation of oxyhemoglobin by ergothioneine and uric acid. Arch Biochem Biophys 294 (1992) 398-402
39. Nagababu E., and Rifkind J.M. Reaction of hydrogen peroxide with ferrylhemoglobin: superoxide production and heme degradation. Biochemistry 39 (2000) 12503-12511
40. Engler H., Taurog A., and Nakashima T. Mechanism of inactivation of thyroid peroxidase by thioureylene drugs. Biochem Pharmacol 31 (1982) 3801-3806